@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_head { this: np:hasAssertion dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_assertion; np:hasProvenance dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_provenance; np:hasPublicationInfo dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_publicationInfo; a np:Nanopublication . dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_assertion a np:Assertion . dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_provenance a np:Provenance . dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_publicationInfo a np:PublicationInfo . } dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_assertion { miriam-gene:185 a ncit:C16612 . lld:C2316810 a ncit:C7057 . dgn-gda:DGN738e65e55e430e4baa673369a74f7fcf sio:SIO_000628 miriam-gene:185, lld:C2316810; a sio:SIO_001121 . } dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_provenance { dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_assertion dcterms:description "[The M235T polymorphism of the angiotensinogen (ANG) gene, the I/D polymorphism of the angiotensin converting enzyme (ACE) gene, and the A1166C polymorphism of the angiotensin II type 1 receptor (AT1R) gene were identified in 70 patients with end-stage renal disease [20 pediatric ESRD, aged 14.9+/-3.1, years blood pressure (BP) 139+/-14/91+/-13 mmHg, 50 adult ESRD, aged 48.7+/-18.7 years, BP 149.1+/-24/96.9+/-12 mmHg], 35 with juvenile essential hypertension (JEHT, aged 14.4+/-2.7 years, 24-h mean BP 135.37+/-7.37/72.4+/-7.68 mmHg), 130 adult healthy normotensive controls (aged 34.9+/-8.1 years, BP 117.8+/-8.7/78.7+/-8.5 mmHg), and 20 pediatric controls (aged 13.2+/-1.2 years, BP 109+/-6.5/71+/-5.9 mmHg).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:12579405; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP323833.RACKFLSxDWzcb2CvQC1s-6InyhEwxqh3m2rbH9pd4-IbM130_publicationInfo { this: dcterms:created "2014-10-02T12:35:09+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }